What is CNS Pharmaceuticals, Inc. Common Stock's Market Cap?

CNS Pharmaceuticals, Inc. Common Stock's Market Cap is $8.7M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value?

CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's EBITDA?

CNS Pharmaceuticals, Inc. Common Stock's EBITDA is -$16.9M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -11.43, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Net Debt?

CNS Pharmaceuticals, Inc. Common Stock's Net Debt is -$20.0M, based on as-reported figures from SEC (XBRL) filings.

CNS Pharmaceuticals, Inc. Common Stock (CNSP) Financial Statements

CNS Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00PM24TS7

XNAS · usd

5.94▲ 0.21 (3.66%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.73

Day's Range5.64 – 5.99

52-Week Range1.88 – 10.59

Volume10.6K

Avg Volume7,308

Share Statistics

Shares Outstanding

Employees8

ExchangeXNAS

Listed2019-11-08

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about CNS Pharmaceuticals, Inc. Common Stock (CNSP)

What is CNS Pharmaceuticals, Inc. Common Stock's Market Cap?: CNS Pharmaceuticals, Inc. Common Stock's Market Cap is $8.7M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value?: CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value is -$11.3M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's EBITDA?: CNS Pharmaceuticals, Inc. Common Stock's EBITDA is -$16.9M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -11.43, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Net Debt?: CNS Pharmaceuticals, Inc. Common Stock's Net Debt is -$20.0M, based on as-reported figures from SEC (XBRL) filings.